Efficacy and Safety of Linagliptin (BI 1356) in Black/African Americans With Type 2 Diabetes With a MTT Sub-study

PHASE3CompletedINTERVENTIONAL
Enrollment

234

Participants

Timeline

Start Date

September 30, 2010

Primary Completion Date

October 31, 2011

Study Completion Date

October 31, 2011

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

Linagliptin

Active drug 1 tablet PO QD

DRUG

Placebo

1 Tablet PO QD

Trial Locations (93)

Unknown

1218.75.059 Boehringer Ingelheim Investigational Site, Birmingham

1218.75.054 Boehringer Ingelheim Investigational Site, Huntsville

1218.75.035 Boehringer Ingelheim Investigational Site, Mobile

1218.75.101 Boehringer Ingelheim Investigational Site, Toney

1218.75.066 Boehringer Ingelheim Investigational Site, Little Rock

1218.75.008 Boehringer Ingelheim Investigational Site, Pell City

1218.75.071 Boehringer Ingelheim Investigational Site, Anaheim

1218.75.018 Boehringer Ingelheim Investigational Site, Chino

1218.75.081 Boehringer Ingelheim Investigational Site, Garden Grove

1218.75.109 Boehringer Ingelheim Investigational Site, Los Angeles

1218.75.040 Boehringer Ingelheim Investigational Site, Colorado Springs

1218.75.047 Boehringer Ingelheim Investigational Site, Denver

1218.75.106 Boehringer Ingelheim Investigational Site, Bartow

1218.75.098 Boehringer Ingelheim Investigational Site, Bradenton

1218.75.036 Boehringer Ingelheim Investigational Site, Chiefland

1218.75.105 Boehringer Ingelheim Investigational Site, Fort Lauderdale

1218.75.083 Boehringer Ingelheim Investigational Site, Fort Myers

1218.75.002 Boehringer Ingelheim Investigational Site, Hialeah

1218.75.080 Boehringer Ingelheim Investigational Site, Jacksonville

1218.75.065 Boehringer Ingelheim Investigational Site, Jupiter

1218.75.007 Boehringer Ingelheim Investigational Site, Miami

1218.75.029 Boehringer Ingelheim Investigational Site, Miami

1218.75.045 Boehringer Ingelheim Investigational Site, Miami

1218.75.084 Boehringer Ingelheim Investigational Site, Miami

1218.75.017 Boehringer Ingelheim Investigational Site, Ocala

1218.75.012 Boehringer Ingelheim Investigational Site, Pinellas Park

1218.75.074 Boehringer Ingelheim Investigational Site, Port Orange

1218.75.076 Boehringer Ingelheim Investigational Site, South Miami

1218.75.003 Boehringer Ingelheim Investigational Site, St. Petersburg

1218.75.039 Boehringer Ingelheim Investigational Site, St. Petersburg

1218.75.075 Boehringer Ingelheim Investigational Site, Tallahassee

1218.75.100 Boehringer Ingelheim Investigational Site, Tamarac

1218.75.015 Boehringer Ingelheim Investigational Site, Tampa

1218.75.103 Boehringer Ingelheim Investigational Site, West Palm Beach

1218.75.049 Boehringer Ingelheim Investigational Site, Atlanta

1218.75.067 Boehringer Ingelheim Investigational Site, Calhoun

1218.75.016 Boehringer Ingelheim Investigational Site, Dunwoody

1218.75.063 Boehringer Ingelheim Investigational Site, Lawrenceville

1218.75.056 Boehringer Ingelheim Investigational Site, Marietta

1218.75.026 Boehringer Ingelheim Investigational Site, Rosswell

1218.75.079 Boehringer Ingelheim Investigational Site, Sandy Springs

1218.75.034 Boehringer Ingelheim Investigational Site, Snellville

1218.75.001 Boehringer Ingelheim Investigational Site, Chicago

1218.75.055 Boehringer Ingelheim Investigational Site, Chicago

1218.75.069 Boehringer Ingelheim Investigational Site, Owensboro

1218.75.044 Boehringer Ingelheim Investigational Site, Baton Rouge

1218.75.108 Boehringer Ingelheim Investigational Site, Essex

1218.75.086 Boehringer Ingelheim Investigational Site, Brockton

1218.75.087 Boehringer Ingelheim Investigational Site, Watertown

1218.75.051 Boehringer Ingelheim Investigational Site, Detroit

1218.75.088 Boehringer Ingelheim Investigational Site, Flint

1218.75.099 Boehringer Ingelheim Investigational Site, Biloxi

1218.75.006 Boehringer Ingelheim Investigational Site, Atco

1218.75.004 Boehringer Ingelheim Investigational Site, Camden

1218.75.031 Boehringer Ingelheim Investigational Site, Brooklyn

1218.75.095 Boehringer Ingelheim Investigational Site, Brooklyn

1218.75.038 Boehringer Ingelheim Investigational Site, Asheboro

1218.75.009 Boehringer Ingelheim Investigational Site, Charlotte

1218.75.023 Boehringer Ingelheim Investigational Site, Charlotte

1218.75.060 Boehringer Ingelheim Investigational Site, Charlotte

1218.75.005 Boehringer Ingelheim Investigational Site, Greensboro

1218.75.107 Boehringer Ingelheim Investigational Site, High Point

1218.75.020 Boehringer Ingelheim Investigational Site, Jacksonville

1218.75.027 Boehringer Ingelheim Investigational Site, Winston-Salem

1218.75.096 Boehringer Ingelheim Investigational Site, Akron

1218.75.090 Boehringer Ingelheim Investigational Site, Columbus

1218.75.078 Boehringer Ingelheim Investigational Site, Dayton

1218.75.037 Boehringer Ingelheim Investigational Site, Philadelphia

1218.75.082 Boehringer Ingelheim Investigational Site, Philadelphia

1218.75.010 Boehringer Ingelheim Investigational Site, Uniontown

1218.75.028 Boehringer Ingelheim Investigational Site, Uniontown

1218.75.091 Boehringer Ingelheim Investigational Site, Anderson

1218.75.072 Boehringer Ingelheim Investigational Site, Columbia

1218.75.068 Boehringer Ingelheim Investigational Site, Greenwood

1218.75.097 Boehringer Ingelheim Investigational Site, Greer

1218.75.024 Boehringer Ingelheim Investigational Site, Brentwood

1218.75.025 Boehringer Ingelheim Investigational Site, Collierville

1218.75.011 Boehringer Ingelheim Investigational Site, Germantown

1218.75.042 Boehringer Ingelheim Investigational Site, Humboldt

1218.75.030 Boehringer Ingelheim Investigational Site, Memphis

1218.75.050 Boehringer Ingelheim Investigational Site, Memphis

1218.75.053 Boehringer Ingelheim Investigational Site, Dallas

1218.75.057 Boehringer Ingelheim Investigational Site, Houston

1218.75.064 Boehringer Ingelheim Investigational Site, Houston

1218.75.104 Boehringer Ingelheim Investigational Site, Houston

1218.75.043 Boehringer Ingelheim Investigational Site, Houton

1218.75.022 Boehringer Ingelheim Investigational Site, San Antonio

1218.75.058 Boehringer Ingelheim Investigational Site, Sugar Land

1218.75.033 Boehringer Ingelheim Investigational Site, Tomball

1218.75.102 Boehringer Ingelheim Investigational Site, Tomball

1218.75.094 Boehringer Ingelheim Investigational Site, Waco

1218.75.092 Boehringer Ingelheim Investigational Site, Whitney

1218.75.019 Boehringer Ingelheim Investigational Site, Virgnia Beach

Sponsors
All Listed Sponsors
collaborator

Eli Lilly and Company

INDUSTRY

lead

Boehringer Ingelheim

INDUSTRY